8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis evaluated 11 randomized controlled trials investigating Nigella sativa in 860 normotensive or hypertensive adults over an average of 8.3 weeks. Compared to control groups, Nigella sativa significantly reduced systolic blood pressure by 3.26 mmHg (95% CI: -5.10, -1.42) and diastolic blood pressure by 2.80 mmHg (95% CI: -4.28, -1.32). Powder formulations showed a greater blood-pressure-lowering effect than oil preparations.
Sahebkar A, Soranna D, Liu X, et al. J Hypertens, 2016. PMID 27512971
2016 / Systematic review and meta-regression of RCTs
A meta-regression analysis of 49 trials (312,175 participants) evaluated cardiovascular risk reductions across 9 approaches to lowering LDL-C. The relative risk of major vascular events per 1-mmol/L (38.7-mg/dL) reduction in LDL-C was 0.77 (95% CI, 0.71-0.84) for statins and 0.75 (95% CI, 0.66-0.86) for nonstatin interventions upregulating LDL receptors (diet, bile acid sequestrants, ileal bypass, and ezetimibe; between-group difference P = .72). For these 5 therapies combined, the RR was 0.77 (95% CI, 0.75-0.79). Achieved LDL-C levels were significantly associated with lower rates of major coronary events in both primary (1.5% lower rate per 1-mmol/L reduction) and secondary prevention trials (4.6% lower rate per 1-mmol/L reduction).
Silverman MG, Ference BA, Im K, et al. JAMA, 2016. PMID 27673306
2016 / Meta-analysis of prospective cohort studies
A meta-analysis of prospective cohort studies published through August 2015 was performed to examine associations between egg intake and risk of CHD and stroke. Comparing high versus low intake (generally 1/day vs. <2/week), egg consumption was linked to a 12% reduced risk of stroke across 7 studies (SRRE = 0.88, 95% CI, 0.81-0.97; I2 = 7.50%). For CHD, the meta-analysis of 7 studies showed a nonstatistically significant SRRE of 0.97 (95% CI, 0.88-1.07; I2 = 0.00%). No clear dose-response trends were seen in stratified or meta-regression analyses.
Shows an association, not proof of cause and effect.
Alexander DD, Miller PE, Vargas AJ, et al. J Am Coll Nutr, 2016. PMID 27710205
2016 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of randomized controlled trials evaluated the effects of almond consumption across 18 publications and 27 almond-control datasets. Using a random-effects model, almond consumption significantly reduced total cholesterol by -0.153 mmol/l (P < 0.001), LDL-cholesterol by -0.124 mmol/l (P = 0.001), and triglycerides (TAG) by -0.067 mmol/l (P = 0.042). HDL-cholesterol was not significantly affected (-0.017 mmol/l; P = 0.207).
Musa-Veloso K, Paulionis L, Poon T, et al. J Nutr Sci, 2016. PMID 27752301
2016 / Systematic review and meta-analysis of cohort studies
A meta-analysis of 16 cohort studies evaluated dietary potassium intake and stroke risk. Comparing the highest with lowest intake categories was associated with a 13% lower stroke risk in blood pressure-adjusted analyses (RR 0.87, 95% CI 0.80-0.94). Spline analysis identified the lowest pooled stroke risk at approximately 90 mmol daily potassium intake (RR 0.78, 95% CI 0.70-0.86 adjusted; RR 0.67, 95% CI 0.57-0.78 unadjusted).
Shows an association, not proof of cause and effect.
Vinceti M, Filippini T, Crippa A, et al. J Am Heart Assoc, 2016. PMID 27792643
2016 / Dose-response meta-analysis of prospective studies
A systematic review and dose-response meta-analysis evaluated 20 prospective studies examining nut consumption and mortality outcomes in adults. A 28 g/day increase in nut intake was associated with reduced risk of coronary heart disease (RR 0.71, 95% CI: 0.63-0.80), cardiovascular disease (RR 0.79, 95% CI: 0.70-0.88), total cancer (RR 0.85, 95% CI: 0.76-0.94), and all-cause mortality (RR 0.78, 95% CI: 0.72-0.84). Inverse associations were also observed for mortality from respiratory disease (RR 0.48), diabetes (RR 0.61), and infectious disease (RR 0.25), with similar findings for tree nuts and peanuts.
Shows an association, not proof of cause and effect.
Aune D, Keum N, Giovannucci E, et al. BMC Med, 2016. PMID 27916000
2016 / Systematic review and meta-analysis of prospective cohort studies
A meta-analysis of 20 prospective cohort studies tracked 2,282,603 participants over 5.5 to 26 years, recording 191,979 deaths. An extra three daily servings (90 g/d) of total whole grains was associated with lower all-cause mortality (RR 0.83; 95% CI: 0.79, 0.88) and a 25% lower risk of cardiovascular mortality. Whole-grain consumption was also inversely associated with total cancer mortality (RR 0.94; 95% CI: 0.91, 0.98).
Shows an association, not proof of cause and effect.
Benisi-Kohansal S, Saneei P, Salehi-Marzijarani M, et al. Adv Nutr, 2016. PMID 28140323
2015 / Systematic review and meta-analysis of prospective observational studies
A meta-analysis of 22 prospective studies encompassing 856,206 individuals evaluated tea intake and cardiovascular endpoints. Increasing tea consumption by three cups daily was associated with lower risk of coronary heart disease (RR 0.73; 95% CI: 0.53-0.99), cardiac death (RR 0.74; 95% CI: 0.63-0.86), stroke (RR 0.82; 95% CI: 0.73-0.92), and total mortality (RR 0.76; 95% CI: 0.63-0.91). No meaningful association was observed for stroke mortality (RR 0.93; 95% CI: 0.83-1.05).
Shows an association, not proof of cause and effect.
Zhang C, Qin YY, Wei X, et al. Eur J Epidemiol, 2015. PMID 25354990
2015 / Meta-analysis of prospective cohort studies
A dose-response meta-analysis evaluated 13 prospective cohort studies covering 252,164 participants and 15,040 cardiovascular disease cases. Each 1 mg per day increase in dietary heme iron was associated with a 7% greater risk of cardiovascular disease (pooled RR 1.07, 95% CI: 1.01 to 1.14). Conversely, non-heme iron (RR 0.98, 95% CI: 0.96 to 1.01) and total iron (RR 1.00, 95% CI: 0.94 to 1.06) showed no association with cardiovascular risk.
Shows an association, not proof of cause and effect.
Fang X, An P, Wang H, et al. Nutr Metab Cardiovasc Dis, 2015. PMID 25439662
2015 / Meta-analysis / review of trials
Previous meta-analyses confirmed that calcium supplements, with or without vitamin D, adversely affected risk of myocardial infarction and, possibly, stroke. Re-analyses have consistently found an adverse effect of calcium on myocardial infarction, though not always statistically significant due to under-powered analyses. Detecting an adverse effect of calcium plus vitamin D depends on whether trials include subjects already taking calcium at baseline or studies at high risk of bias. The authors note the mechanisms remain uncertain but suggest the risks of calcium supplements outweigh any small benefits on fracture incidence.
Reid IR, Bristow SM, Bolland MJ J Cell Biochem, 2015. PMID 25491763
2015 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis analyzed 27 randomized controlled clinical trials involving 2,569 patients. For type 2 diabetes, berberine with lifestyle intervention or oral hypoglycemics tended to lower FPG, PPG, and HbA1c more than lifestyle intervention alone, placebo, or hypoglycemics alone, though berberine alone did not significantly differ from oral hypoglycemics. For hyperlipidemia, berberine combined with lifestyle intervention or lipid-lowering drugs was better at reducing TC and LDL-C and raising HDL-C. For hypertension, berberine with lifestyle intervention or hypotensors lowered blood pressure more than controls. No serious adverse reactions were reported, but the authors concluded that due to limited overall study quality, the therapeutic benefit could be substantiated to a limited degree.
Lan J, Zhao Y, Dong F, et al. J Ethnopharmacol, 2015. PMID 25498346
2015 / Meta-analysis of prospective observational studies
A meta-analysis of 12 prospective observational studies with 23,623 participants evaluated baseline homocysteine levels and mortality. Comparing the highest to lowest categories, participants with elevated homocysteine had higher risks of coronary heart disease mortality (RR 1.66; 95% CI: 1.12-2.47), cardiovascular mortality (RR 1.68; 95% CI: 1.04-2.70), and all-cause mortality (RR 1.93; 95% CI: 1.54-2.43). Each 5 μmol/L increase was also associated with elevated mortality across all three outcomes.
Shows an association, not proof of cause and effect.
Peng HY, Man CF, Xu J, et al. J Zhejiang Univ Sci B, 2015. PMID 25559959
2015 / Systematic review of clinical studies
A systematic review critically evaluated clinical evidence from 26 clinical studies on dietary pomegranate preparations in the prevention and treatment of cardiovascular diseases. Overall study quality was poor, and even in the best studies, indications of benefit did not reach conventional levels of statistical significance. The only study with a definitive design evaluated a biochemical endpoint (blood concentrations of myeloperoxidase after a single dose) rather than a clinical endpoint, and only 10 of the 26 studies reported HPLC data on co-active ingredients.
Vlachojannis C, Erne P, Schoenenberger AW, et al. Phytother Res, 2015. PMID 25611333
2015 / Meta-analysis of prospective cohort studies
A meta-analysis evaluated 15 prospective cohorts encompassing 1,020,642 participants. Top-tier adherence to HEI, AHEI, or DASH was associated with lower total mortality (RR 0.78, 95% CI 0.76 to 0.80), cardiovascular events or death (RR 0.78, 95% CI 0.75 to 0.81), malignancies (RR 0.85, 95% CI 0.82 to 0.88), and type 2 diabetes (RR 0.78, 95% CI 0.72 to 0.85). Neurodegenerative conditions showed no significant relationship.
Shows an association, not proof of cause and effect.
Schwingshackl L, Hoffmann G J Acad Nutr Diet, 2015. PMID 25680825
2015 / Pooled analysis of prospective cohort studies
Researchers analyzed 82,486 participants across three prospective UK cohorts with 1,305,330 person-years of follow-up and 8,857 deaths. Compared to consuming tinned fruit less than once per month, adjusted pooled hazard ratios for all-cause mortality were 1.05 (95% CI: 0.99, 1.12) for 1-3 servings/month, 1.10 (95% CI: 1.03, 1.18) for 1 serving/week, and 1.13 (95% CI: 1.04, 1.23) for two or more servings/week. Tinned fruit intake was also associated with cardiovascular mortality and non-cardiovascular, non-cancer mortality.
Shows an association, not proof of cause and effect.
Aasheim ET, Sharp SJ, Appleby PN, et al. PLoS One, 2015. PMID 25714554
2015 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated 7 randomized placebo-controlled trials investigating garlic for blood pressure management in hypertensive patients. Compared to placebo, garlic significantly decreased systolic blood pressure (WMD: -6.71 mmHg; 95% CI: -12.44 to -0.99; P = 0.02) and diastolic blood pressure (WMD: -4.79 mmHg; 95% CI: -6.60 to -2.99; P < 0.00001). No serious adverse events were documented across the trials.
Xiong XJ, Wang PQ, Li SJ, et al. Phytomedicine, 2015. PMID 25837272
2015 / Pooled analysis of prospective cohorts
Data from 6 prospective cohort studies totaling 661,137 men and women were pooled to evaluate the dose-response relationship between leisure time physical activity and mortality over a median follow-up of 14.2 years. Compared with no activity, mortality risk was lower among those performing less than the recommended minimum of 7.5 MET-hours/week (HR 0.80), 1 to 2 times the minimum (HR 0.69), and 2 to 3 times the minimum (HR 0.63). An upper threshold of benefit was seen at 3 to 5 times the recommended minimum (HR 0.61), with no evidence of harm observed at 10 or more times the minimum (HR 0.69). Similar dose-response associations were found for cardiovascular disease and cancer mortality.
Shows an association, not proof of cause and effect.
Arem H, Moore SC, Patel A, et al. JAMA Intern Med, 2015. PMID 25844730
2015 / Mendelian randomization meta-analysis
Researchers examined associations of BMI and a 32-SNP genetic score with cardiovascular outcomes in up to 22,193 individuals (3,062 incident cardiovascular events) across nine prospective studies using random-effects meta-analysis in a Mendelian randomization framework. In observational analyses, BMI associated with incident CHD (HR = 1.20 per SD increase), heart failure (HR = 1.47), and ischaemic stroke (HR = 1.15). Mendelian randomization indicated a causal effect of adiposity on heart failure (HR = 1.93 per SD increase of BMI, 95% CI, 1.12-3.30) and ischaemic stroke (HR = 1.83, 95% CI, 1.05-3.20), with additional analyses also showing a causal effect on CHD.
Hägg S, Fall T, Ploner A, et al. Int J Epidemiol, 2015. PMID 26016847
2015 / Systematic review and meta-analysis of prospective cohort studies
In a systematic review of 23 cohort studies, 20 out of 51 evaluated blood-borne indicators were associated with mortality risk. Meta-analyses identified associations between mortality and C-reactive protein (all-cause HR 1.42, p<0.001; cancer HR 1.62, p<0.009; CVD HR 1.31, p=0.033), NT-proBNP, and white blood cell count. Several additional markers showed potential utility, whereas others had equivocal support or lacked fatal risk connections.
Shows an association, not proof of cause and effect.
Barron E, Lara J, White M, et al. PLoS One, 2015. PMID 26039142
2015 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of 15 randomized controlled trials with approximately 59,000 participants found that reducing dietary saturated fat decreased cardiovascular events by 17% (RR 0.83; 95% CI 0.72 to 0.96). Effects on all-cause mortality (RR 0.97; 95% CI 0.90 to 1.05) and cardiovascular mortality (RR 0.95; 95% CI 0.80 to 1.12) were less clear. Cardiovascular risk reductions appeared driven by replacing saturated fat calories with polyunsaturated fats rather than carbohydrates or protein.
Hooper L, Martin N, Abdelhamid A, et al. Cochrane Database Syst Rev, 2015. PMID 26068959
2015 / Prospective cohort study and systematic review with meta-analysis
In the EPIC-Norfolk cohort (20,951 adults), the top quintile of chocolate consumption (16-99 g/day) versus non-consumption was associated with lower risk of stroke (multivariate-adjusted HR 0.77, 95% CI 0.62 to 0.97) and cardiovascular disease (HR 0.86, 95% CI 0.76 to 0.97), with CHD at HR 0.88 (95% CI 0.77 to 1.01). A meta-analysis of nine studies (157,809 participants) found higher intake was associated with significantly lower risk of CHD (RR 0.71, 95% CI 0.56 to 0.92), stroke (RR 0.79, 95% CI 0.70 to 0.87), and cardiovascular mortality (RR 0.55, 95% CI 0.36 to 0.83). The authors note residual confounding cannot be excluded.
Shows an association, not proof of cause and effect.
Kwok CS, Boekholdt SM, Lentjes MA, et al. Heart, 2015. PMID 26076934
2015 / Dose-response meta-analysis of prospective cohort studies
A dose-response meta-analysis of 18 prospective cohort studies examined tea intake and cause-specific mortality. Green tea consumption was inversely associated with cardiovascular mortality (highest vs. lowest RR 0.67; 95% CI: 0.46, 0.96) and all-cause mortality (RR 0.80; 95% CI: 0.68, 0.93). Black tea was inversely associated with cancer mortality (RR 0.79; 95% CI: 0.65, 0.97) and all-cause mortality (RR 0.90; 95% CI: 0.83, 0.98).
Shows an association, not proof of cause and effect.
Tang J, Zheng JS, Fang L, et al. Br J Nutr, 2015. PMID 26202661
2015 / Prospective cohort studies and fixed-effects meta-analysis
Researchers analyzed the association between long-term intake of animal flesh and incident hypertension across three prospective cohorts: NHS, NHS II, and HPFS, followed by a fixed-effects meta-analysis. Compared with intake of less than 1 serving/month, consumption of at least 1 serving/day was associated with pooled hazard ratios of 1.30 (95% CI 1.23-1.39) for total meat, 1.22 (95% CI 1.12-1.34) for poultry, and 1.05 (95% CI 0.98-1.13) for seafood. Consuming any animal flesh at least 1 serving/day was linked to higher risk [pooled HR = 1.30 (95% CI 1.16-1.47)]. Seafood consumption showed a weak but significant trend toward increased hypertension risk, being associated with risk in HPFS and NHS II, but not NHS.
Shows an association, not proof of cause and effect.
Borgi L, Curhan GC, Willett WC, et al. J Hypertens, 2015. PMID 26237562
2015 / Meta-analysis of randomised controlled trials
A meta-analysis of 35 randomised controlled trials (50 comparisons) with treatment durations from 4 weeks to 1 year evaluated the effects of soya on lipid profiles. Soya intake significantly reduced serum LDL-cholesterol by -4.83 mg/dl, TAG by -4.92 mg/dl, and total cholesterol by -5.33 mg/dl, while increasing HDL-cholesterol by 1.40 mg/dl. High heterogeneity was observed, with I² ranging from 92 to 99%. Reductions in LDL were larger in hypercholesterolaemic patients (-7.47 mg/dl) than healthy subjects (-2.96 mg/dl), and stronger for whole soya products (-11.06 mg/dl) than processed soya extracts (-3.17 mg/dl), while isoflavone supplementation had no effect on lipids.
Tokede OA, Onabanjo TA, Yansane A, et al. Br J Nutr, 2015. PMID 26268987